The Asia CRO Alliance supports drug, biotech, medical device companies, and CROs planning studies in Asia. The ACA led by LSK Global Pharma Services, the largest local Korean CRO, meets the increasing demand for Asian studies. ACA members function individually or in team as the sponsor demands. At present LSK is engaged in a pivotal oncology study of 95 sites from 12 countries in Asia, US, and Europe with some ACA members. ACA services are of global quality, timely and price-conscious.